Home > Qtrly Results > DR REDDYS LABORATORIES

DR REDDYS LABORATORIES
Quarterly Results Analysis [Mar2025]

DR REDDYS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for DR REDDYS LABORATORIES
Please provide your vote to see the results

DR REDDYS LABORATORIES Quarterly Results

Consolidated Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
Audited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
Audited
Jun2023
UnAudited
Revenues ₹8,528 Cr ₹8,381 Cr ₹8,038 Cr ₹7,696 Cr ₹7,114 Cr ₹7,237 Cr ₹6,903 Cr ₹6,758 Cr
Expenses ₹6,531 Cr ₹6,108 Cr ₹5,962 Cr ₹5,566 Cr ₹5,283 Cr ₹5,214 Cr ₹4,894 Cr ₹4,696 Cr
Operating Income ₹1,998 Cr ₹2,273 Cr ₹2,077 Cr ₹2,130 Cr ₹1,831 Cr ₹2,023 Cr ₹2,008 Cr ₹2,062 Cr
Other Income ₹522 Cr ₹150 Cr ₹308 Cr ₹187 Cr ₹198 Cr ₹216 Cr ₹315 Cr ₹174 Cr
Interest ₹66 Cr ₹82 Cr ₹76 Cr ₹60 Cr ₹59 Cr ₹39 Cr ₹35 Cr ₹37 Cr
Depreciation ₹455 Cr ₹471 Cr ₹397 Cr ₹381 Cr ₹368 Cr ₹374 Cr ₹376 Cr ₹353 Cr
Profit Before Tax ₹2,000 Cr ₹1,870 Cr ₹1,911 Cr ₹1,877 Cr ₹1,602 Cr ₹1,826 Cr ₹1,913 Cr ₹1,846 Cr
Profit After Tax ₹1,581 Cr ₹1,400 Cr ₹1,336 Cr ₹1,387 Cr ₹1,306 Cr ₹1,378 Cr ₹1,478 Cr ₹1,401 Cr
EPS ₹19.10 ₹16.95 ₹15.06 ₹16.70 ₹78.53 ₹16.56 ₹17.77 ₹16.87
Industry Peers & Returns1W1M1Y
DR REDDYS LABORATORIES 5.7% 15% 11.5%
SUN PHARMACEUTICAL INDUSTRIES 0.3% -4.9% 15.8%
DIVIS LABORATORIES 0.2% 10% 53.5%
CIPLA 2.3% 1.1% 2.6%
TORRENT PHARMACEUTICALS 0.8% -0.9% 17.4%
MANKIND PHARMA -2.5% -3.3% 11.1%
ZYDUS LIFESCIENCES 3.3% 10.1% -7.4%
LUPIN 2% -0.7% 26%
AUROBINDO PHARMA 2.2% 0.2% -5.5%

DR REDDYS LABORATORIES Quarterly Revenues

Revenues
Q-o-Q

1.76 %

Y-o-Y

19.89 %

Quarters Revenues % Change
Mar2025 ₹8,528 Cr
1.76
Dec2024 ₹8,381 Cr
4.27
Sep2024 ₹8,038 Cr
4.45
Jun2024 ₹7,696 Cr
8.19
Mar2024 ₹7,114 Cr
-1.70
Dec2023 ₹7,237 Cr
4.84
Sep2023 ₹6,903 Cr
2.14
Jun2023 ₹6,758 Cr -

DR REDDYS LABORATORIES Quarterly Operating Profit

Operating Profit
Q-o-Q

-12.10 %

Y-o-Y

9.10 %

Quarters Operating Profit % Change
Mar2025 ₹1,998 Cr
-12.10
Dec2024 ₹2,273 Cr
9.46
Sep2024 ₹2,077 Cr
-2.51
Jun2024 ₹2,130 Cr
16.31
Mar2024 ₹1,831 Cr
-9.49
Dec2023 ₹2,023 Cr
0.74
Sep2023 ₹2,008 Cr
-2.61
Jun2023 ₹2,062 Cr -
Operating Margins
Q-o-Q

-13.61 %

Y-o-Y

-8.97 %

Quarters Operating Margin% % Change
Mar2025 23.43%
-13.61
Dec2024 27.12%
4.99
Sep2024 25.83%
-6.68
Jun2024 27.68%
7.54
Mar2024 25.74%
-7.94
Dec2023 27.96%
-3.88
Sep2023 29.09%
-4.65
Jun2023 30.51% -

DR REDDYS LABORATORIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

12.94 %

Y-o-Y

21.04 %

Quarters Profit After Tax % Change
Mar2025 ₹1,581 Cr
12.94
Dec2024 ₹1,400 Cr
4.81
Sep2024 ₹1,336 Cr
-3.66
Jun2024 ₹1,387 Cr
6.14
Mar2024 ₹1,306 Cr
-5.22
Dec2023 ₹1,378 Cr
-6.75
Sep2023 ₹1,478 Cr
5.52
Jun2023 ₹1,401 Cr -
PAT Margins
Q-o-Q

11.02 %

Y-o-Y

0.98 %

Quarters PAT Margin(%) % Change
Mar2025 18.54 %
11.02
Dec2024 16.7 %
0.48
Sep2024 16.62 %
-7.77
Jun2024 18.02 %
-1.85
Mar2024 18.36 %
-3.57
Dec2023 19.04 %
-11.07
Sep2023 21.41 %
3.28
Jun2023 20.73 % -

DR REDDYS LABORATORIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

12.68 %

Y-o-Y

-75.68 %

Quarters EPS % Change
Mar2025 ₹19.1
12.68
Dec2024 ₹16.95
12.55
Sep2024 ₹15.06
-9.82
Jun2024 ₹16.7
-78.73
Mar2024 ₹78.53
374.21
Dec2023 ₹16.56
-6.81
Sep2023 ₹17.77
5.33
Jun2023 ₹16.87 -

You may also like the below Video Courses